» Articles » PMID: 32444239

Ectopic Expression of SOX18 in Basal Cell Carcinoma Negatively Regulates Tumour Progression

Overview
Journal J Dermatol Sci
Publisher Elsevier
Specialty Dermatology
Date 2020 May 24
PMID 32444239
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Basal Cell Carcinoma is the most common tumour and yet much remains to be determined regarding the molecular mechanisms that leads to its development. Hedgehog signal activation is sufficient for BCC induction, but the molecular mediators of BCC growth are not well understood. SoxF transcription factor Sox18 has been identified in human BCC, but its role in growth of the tumour is as yet unknown.

Objective: To determine if Sox18 is involved in the regulation of Basal Cell Carcinoma growth.

Methods: We analysed the function of Sox18 by combining a dominant negative Sox18 mouse model, Sox18 with murine BCC RESULTS: We determine that Sox18 is ectopically expressed in the epidermal cells of a murine model of Basal Cell Carcinoma. We then show that dominant negative mutation of Sox18 increases the severity of murine Basal Cell Carcinoma. Finally, decreased Hey1 in Sox18 BCC suggests Sox18 may negatively regulate BCC progression via Notch signaling.

Conclusions: These data suggest that Sox18 is a hedgehog regulated mediator of tumour suppression within Basal Cell Carcinoma epidermis.

Citing Articles

[Effects of propranolol on the biological behavior of human umbilical vein endothelial cells and the expression of SOX18, MMP-7, and VEGFA].

Zhou P, Xie S, Zhong L, Ding X Zhongguo Dang Dai Er Ke Za Zhi. 2024; 26(10):1115-1121.

PMID: 39467683 PMC: 11527407. DOI: 10.7499/j.issn.1008-8830.2407088.


Photodynamic Therapy for Basal Cell Carcinoma: The Clinical Context for Future Research Priorities.

Collier N, Rhodes L Molecules. 2020; 25(22).

PMID: 33218174 PMC: 7698957. DOI: 10.3390/molecules25225398.